Skip to main content

Jin Ha Park

Yonsei University · Medicine

About the Lab

Professor Jin Ha Park's research lab specializes in translational biomedical research, focusing on molecular diagnostics, targeted cancer therapies, and stem cell imaging. Key research directions include optimizing HER-2 testing methods for breast cancer, developing and evaluating reporter gene systems for long-term cell tracking, and advancing molecular imaging techniques such as PET/CT using radiolabeled antibodies. The lab also explores novel antibody engineering and biomaterials for improved therapeutic and diagnostic applications.

HER-2 diagnosticsmolecular imagingstem cell trackingantibody engineeringPET/CT

Research Overview

Papers
101
Total Citations
2,312
Papers (5y)
42
Primary Field
Medicine

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
42total
2021
2022
2023
2024
2025
Citations per year (5y)
85total
20212022202320242025

Selected Papers

15
1
Article|389 citations·2002
Evaluation of HER-2/neu Gene Amplification and Overexpression: Comparison of Frequently Used Assay Methods in a Molecularly Characterized Cohort of Breast Cancer Specimens
Michael F. Press, Dennis J. Slamon, Kerry Flom, Jinha Park, Jianyuan Zhou, Leslie Bernstein
SJR Q1Journal of Clinical Oncology

PURPOSE: To compare and evaluate HER-2/neu clinical assay methods. MATERIALS AND METHODS: One hundred seventeen breast cancer specimens with known HER-2/neu amplification and overexpression status were assayed with four different immunohistochemical assays and two different fluorescence in situ hybridization (FISH) assays. RESULTS: The accuracy of the FISH assays for HER-2/neu gene amplification was high, 97.4% for the Vysis PathVision assay (Vysis, Inc, Downers Grove, IL) and 95.7% for the the

OncologyMedicine
2
Article|314 citations·2010
Quantification of Hemodynamics in Abdominal Aortic Aneurysms During Rest and Exercise Using Magnetic Resonance Imaging and Computational Fluid Dynamics
Andrea S. Les, Shawn C. Shadden, C. Alberto Figueroa, Jinha Park, Maureen M. Tedesco, Robert J. Herfkens, Ronald L. Dalman, Charles A. Taylor
SJR Q2Annals of Biomedical EngineeringOA
Pulmonary and Respiratory MedicineMedicine
3
Article|311 citations·2005
Diagnostic Evaluation of HER-2 as a Molecular Target: An Assessment of Accuracy and Reproducibility of Laboratory Testing in Large, Prospective, Randomized Clinical Trials
Michael F. Press, Guido Sauter, Leslie Bernstein, Ivonne Villalobos, Martina Mirlacher, Jianyuan Zhou, Rooba Wardeh, Yong-Tian Li, Roberta Guzman, Yanling Ma, Jane Sullivan‐Halley, Angela Santiago
SJR Q1Clinical Cancer ResearchOA

PURPOSE: To critically assess the accuracy and reproducibility of human epidermal growth factor receptor type 2 (HER-2) testing in outside/local community-based hospitals versus two centralized reference laboratories and its effect on selection of women for trastuzumab (Herceptin)-based clinical trials. EXPERIMENTAL DESIGN: Breast cancer specimens from 2,600 women were prospectively evaluated by fluorescence in situ hybridization (FISH) for entry into Breast Cancer International Research Group (

OncologyMedicine
4
Article|138 citations·2005
Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging
Manickam Krishnan, Jinha Park, Feng Cao, Dongxu Wang, Ramasamy Paulmurugan, Jeffrey R. Tseng, Mark L. Gonzalgo, Sanjiv S. Gambhir, Joseph C. Wu
SJR Q1The FASEB JournalOA

Tracking stem cell localization, survival, differentiation, and proliferation after transplantation in living subjects is essential for understanding stem cell biology and physiology. In this study, we investigated the long-term stability of reporter gene expression in an embryonic rat cardiomyoblast cell line and the role of epigenetic modulation on reversing reporter gene silencing. Cells were stably transfected with plasmids carrying cytomegalovirus promoter driving firefly luciferase reporte

GeneticsBiochemistry, Genetics and Molecular Biology
5
Article|95 citations·2017
Tumor Uptake of 64Cu-DOTA-Trastuzumab in Patients with Metastatic Breast Cancer
Joanne Mortimer, James R. Bading, Jinha Park, Paul Frankel, Mary Carroll, Tri Manh Tran, Erasmus Poku, Russell C. Rockne, Andrew Raubitschek, John E. Shively, David Colcher
SJR Q1Journal of Nuclear MedicineOA

The goal of this study was to characterize the relationship between tumor uptake of <sup>64</sup>Cu-DOTA-trastuzumab as measured by PET/CT and standard, immunohistochemistry (IHC)-based, histopathologic classification of human epidermal growth factor receptor 2 (HER2) status in women with metastatic breast cancer (MBC). <b>Methods:</b> Women with biopsy-confirmed MBC and not given trastuzumab for 2 mo or more underwent complete staging, including <sup>18</sup>F-FDG PET/CT. Patients were classifi

OncologyMedicine
6
Article|87 citations·2004
Characterization of engineered anti-p185HER-2 (scFv-CH3)2 antibody fragments (minibodies) for tumor targeting
Tove Olafsen, Guifu Tan, C W Cheung, Paul J. Yazaki, Jinha Park, John E. Shively, Lawrence E. Williams, Andrew Raubitschek, Michael F. Press, Anna M. Wu
SJR Q1Protein Engineering Design and SelectionOA

An engineered antibody fragment (minibody; scFv-C(H)3gamma(1) dimer, M(r) 80 000) specific for carcinoembryonic antigen (CEA) has previously demonstrated excellent tumor targeting coupled with rapid clearance in vivo. In this study, variable (V) genes from the anti- p185(HER-2) 10H8 antibody were similarly assembled and expressed. Four constructs were made: first, the V genes were assembled in both orientations (V(L)-linker-V(H) and V(H)-linker-V(L)) as single chain Fvs (scFvs). Then each scFv w

Radiology, Nuclear Medicine and ImagingMedicine
7
Article|84 citations·2008
Formation of a bimodal eutectic structure in Ti–Fe–Sn alloys with enhanced plasticity
Jun Han, K. B. Kim, So Young Yi, Jinha Park, Sangho Sohn, T. E. Kim, D. H. Kim, J. Das, J. Eckert
SJR Q1Applied Physics Letters

Microstructural investigations on a series of (Ti70.5Fe29.5)100−xSnx alloys with x=5, 7, and 9 reveal that Sn addition is effective in introducing both structural and spatial heterogeneities in ultrafine eutectic composites stemming from a large temperature difference between two eutectic temperatures upon solidification. The microstructural heterogeneities in these ultrafine eutectic composites strongly enhance the room temperature compressive plasticity up to ∼15.7%.

Mechanical EngineeringEngineering
8
Article|69 citations·2010
Enhancement of plastic deformability in Fe–Ni–Nb–B bulk glassy alloys by controlling the Ni-to-Fe concentration ratio
Jinha Park, G. Wang, Ran Li, N. Mattern, J. Eckert, D. H. Kim
SJR Q1Applied Physics Letters

The influence of partial replacement of Fe by Ni in (Fe1−xNix)71Nb6B23 (0≤x≤0.5) bulk glassy alloys on the enhancement of the plasticity has been investigated. The increase of the Ni-to-Fe concentration ratio effectively improves the compressive plasticity. The (Fe0.5Ni0.5)71Nb6B23 alloy exhibits an enhanced plastic strain of ∼4.2%, together with high strength and distinct strain hardeninglike characteristics, when compared with the Ni-free Fe71Nb6B23 glass. The improved mechanical properties ar

Mechanical EngineeringEngineering
9
Article|60 citations·2009
64Cu-Labeled Affibody Molecules for Imaging of HER2 Expressing Tumors
Zhen Cheng, Omayra Padilla De Jesus, Daniel J. Kramer, Abhijit De, Jack M. Webster, Olivier Gheysens, Jelena Levi, Mohammad Namavari, Sen Wang, Jinha Park, Rong Zhang, Hongguang Liu
SJR Q2Molecular Imaging and Biology
Radiology, Nuclear Medicine and ImagingMedicine
10
Article|58 citations·2018
Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer
Mei Gao, Miranda Lin, Richard A. Moffitt, Marcela A. Salazar, Jinha Park, Jeffrey Vacirca, Chuan Huang, Kenneth R. Shroyer, Minsig Choi, Georgios Georgakis, Aaron R. Sasson, Mark A. Talamini
SJR Q1British Journal of CancerOA

BACKGROUND: Pancreatic cancer (PC) hijacks innate cellular processes to promote cancer growth. We hypothesized that PC exploits PD-1/PD-L1 not only to avoid immune responses, but to directly enhance growth. We also hypothesized that immune checkpoint inhibitors (ICIs) have direct cytotoxicity in PC. We sought to elucidate therapeutic targeting of PD-1/PD-L1. METHODS: PD-1 was assessed in PC cells, patient-derived organoids (PDOs), and clinical tissues. Then, PC cells were exposed to PD-L1 to eva

OncologyMedicine
11
Article|38 citations·2010
Ductile Ti-Based Bulk Metallic Glasses with High Specific Strength
Jinha Park, G. Wang, S. Pauly, N. Mattern, D. H. Kim, J. Eckert
SJR Q1Metallurgical and Materials Transactions A
Mechanical EngineeringEngineering
12
Article|38 citations·2005
Multimodality Radionuclide, Fluorescence, and Bioluminescence Small-Animal Imaging
Jinha Park, Sanjiv S. Gambhir
SJR Q1Proceedings of the IEEE

The imaging of molecular events in the complex physiological interplay between organelles, cells, tissues, and organs in the whole organism is now more practical through the use of small-animal imaging technologies. Radionuclide based molecular imaging using single photon emission computed tomography (SPECT) and positron emission tomography (PET) scanners have been used for imaging intracellular enzymes, receptors, transporters, reporter gene expression, and cell trafficking in small animals suc

Molecular BiologyBiochemistry, Genetics and Molecular Biology
13
Article|27 citations·2010
Improving the plasticity of a high strength Fe–Si–Ti ultrafine composite by introduction of an immiscible element
Jinha Park, D. H. Kim, K. B. Kim, J. Eckert
SJR Q1Applied Physics Letters

A heterostructured Fe71Si15Ti10Cu4 ultrafine composite has been developed. The addition of Cu with large positive enthalpy of mixing with the main constituent element (Fe) leads to evolution of a unique microstructure with different length-scale heterogeneities, i.e., formation of spherical colonies containing length-scale heterogeneity of lamellar spacing and precipitation of nanoscale multitwinned Cu within α-Fe layers. These macroscopic and microscopic structural heterogeneities are able to s

Materials ChemistryMaterials Science
14
Article|16 citations·1999
Assessment of Novel Anti-pl85 HER-2 Monoclonal Antibodies for Internalization-Dependent Therapies
Jinha Park, Xiaowei Yang, John J. Park, Oliver W. Press, Michael F. Press
HybridomaOA

Novel therapies that require internalization of effector domains may be improved by assessing the efficacy of postbinding receptor-mediated endocytosis. To achieve targeted gene therapy of immunotoxin therapy, natural vector-host tropisms must be altered. Recent improvements in monoclonal antibody (MAb) engineering have expanded the potential range of host cells that can be targeted for therapeutic intervention. However, relatively little is known about cellular responses after binding of a vect

ImmunologyImmunology and Microbiology
15
Article|11 citations·2006
Promising techniques for breast cancer detection, diagnosis, and staging using non-ionizing radiation imaging techniques
Jinha Park, Debra M. Ikeda
SJR Q1Physica Medica
Biomedical EngineeringEngineering

Research Areas

Cancer ResearchPulmonary and Respiratory MedicineRadiology, Nuclear Medicine and ImagingOncologyMechanical EngineeringSurgery

Dive deeper into Jin Ha Park's research on Nubint

Open this lab's papers in the app to read with AI, summarize, and cite in your writing.